Briefing: Soil health index finds restored mangroves can near full function
Strategic angle: Brazilian researchers have developed an index to measure mangrove soil health, showing restored areas can achieve near full functionality.
Briefing: What’s next for RFK Jr.’s MAHA allies on vaccine policy?
Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.
BioNTech Founders to Depart, Form New mRNA-Focused Company
Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm.
Briefing: Amid dueling autism meetings, HHS cancels
Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news
Briefing: Who's making money off Trump's war in Iran?
Strategic angle: A look into the financial interests behind the ongoing conflict and its implications.
Briefing: Removing race from kidney function algorithm helped more Black patients access transplants
Strategic angle: A significant change in the eGFR algorithm led to increased kidney transplant opportunities for Black patients.
Briefing: Golfer Woodland opens up about PTSD diagnosis
Strategic angle: Gary Woodland reveals his struggle with post-traumatic stress disorder following brain surgery.
Briefing: Gene edit makes probiotic safer for immunocompromised patients
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
Briefing: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial
Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials.
Briefing: Men who brought explosives to NYC protest cited Islamic State as inspiration, complaint says
Strategic angle: Two individuals arrested for carrying explosives at a protest in New York City reportedly cited the Islamic State as their motivation.
Briefing: CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Strategic angle: A groundbreaking approach using CRISPR technology shows promise in treating heart failure by enhancing mitochondrial function.
Briefing: Unlocking the hidden pocket on a billion‑dollar drug target
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Briefing: Key protein SYFO2 enables 'self-fertilization' of leguminous plants
Strategic angle: Research reveals how SYFO2 protein facilitates self-fertilization in legumes, enhancing agricultural efficiency.
Briefing: ‘Cash Apples’ is giving away $500,000 to people who click on trees in a web browser
Strategic angle: Want to make real money just by clicking on virtual trees? Starting today, residents of the United States can begin an online hunt for golden apples.
Briefing: The ER Staffing Conflict and No Facility Fee for a Marmot
Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Briefing: A setback for Roche’s breast cancer drug
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Briefing: Fresh turmoil at the FDA with Prasad’s exit
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Briefing: Talkspace to be acquired for $835 million by mental health services giant
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Briefing: Health tech company says it will dive into Medicare’s new chronic care experiment
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.
Evaluating the Risks of AI Chatbots for Medical Advice
The launch of ChatGPT Health by OpenAI prompts a critical examination of the risks associated with AI-driven health consultations.